首页> 外文期刊>Molecular Genetics & Genomic Medicine >Comparison of suspected Lynch syndrome patients carrying BRCA and BRCA‐like variants with Lynch syndrome probands: Phenotypic characteristics and pedigree analyses
【24h】

Comparison of suspected Lynch syndrome patients carrying BRCA and BRCA‐like variants with Lynch syndrome probands: Phenotypic characteristics and pedigree analyses

机译:携带BRCA和BRCA样变体的疑似林氏综合征患者的比较林奇综合征验证:表型特征及血统分析

获取原文
           

摘要

Background Colorectal cancer (CRC) patients diagnosed with Lynch syndrome (LS) are recommended genetic testing. Increasing numbers of germline variants involved in homologous recombination have been identified in suspected LS patients. This study compared phenotypic the characteristics of suspected LS patients carrying BRCA and BRCA‐like variants with those of LS patients. Methods Forty‐two patients carrying pathogenic variants of DNA mismatch repair (MMR) genes (MMR group), 9 carrying BRCA variants, and 11 carrying BRCA‐like variants (BRCA/BRCA‐like group) who met LS clinical criteria were enrolled in this study. Clinical characteristics, pedigrees, and survival rates were compared and BRCA variants were analyzed. Results The earliest CRC‐onset age and tumor differentiation were higher in the BRCA/BRCA‐like group than in the MMR group. Metachronous CRCs were more numerous in the MMR group, resulting in a higher progression‐free survival rate in the BRCA/BRCA‐like group. Extra‐colorectal cancers were more frequently observed in the BRCA/BRCA‐like group. BRCA2 and BRCA1 variants were clustered in exons 11 and 4/7, respectively. Conclusion BRCA and BRCA‐like variants in CRC patients with LS showed moderate penetrance. BRCA/BRCA‐like variant carriers had a higher risk for extra‐colorectal cancers. Surveillance of susceptible organs other than the intestine should be performed for probands and affected family members.
机译:背景技术癌症患者(CRC)患者被诊断为林奇综合征(LS)是遗传检测。在疑似LS患者中鉴定了增加涉及同源重组的种系变体数量。该研究比较了表型患有BRCA和BRCA样变种的疑似LS患者的特征。方法对患有LS临床标准的携带BRCA变体(MMR)基因(MMR)基因(MMR)基因(MMR组),9种携带的BRCA样变体(BRCA / BRCA样组)进行致病性变异的四十二次患者学习。比较临床特征,群体和存活率,分析了BRCA变体。结果BRCA / BRCA样组中最早的CRC发作年龄和肿瘤分化均高于MMR组。 MMR组中等CRC在MMR组中较多,导致BRCA / BRCA族的无进展的存活率。在BRCA / BRCA的组中更常见地观察到结直肠癌。 BRCA2和BRCA1分别分别在外显子11和4/7中聚集。结论BRC和BRCA样变体在CRC患者LS中显示出中度渗透。 BRCA / BRCA样变体载体具有更高的癌症癌症的风险较高。应对肠道以外的易感器官进行监测,并对胰岛素和受影响的家庭成员进行。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号